{"id":703885,"date":"2024-06-24T19:38:02","date_gmt":"2024-06-24T19:38:02","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=703885"},"modified":"2024-06-24T19:38:02","modified_gmt":"2024-06-24T19:38:02","slug":"therapeutic-hypothermia-systems-market-worth-396-million-by-2028","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/therapeutic-hypothermia-systems-market-worth-396-million-by-2028_703885.html","title":{"rendered":"Therapeutic Hypothermia Systems Market worth $396 million by 2028"},"content":{"rendered":"
\n
\"Therapeutic<\/a><\/div>\n
\n
Major players in the therapeutic hypothermia systems market include ZOLL Medical Corporation (Japan), Becton, Dickinson and Company (US), and Stryker Corporation (US).<\/div>\n<\/div>\n<\/div>\n
Browse 132 market data Tables and 39 Figures spread through 173 Pages and in-depth TOC on “Therapeutic Hypothermia Systems Market by Product (Cooling Devices, Cooling Catheters, Cool Caps), Application (Neurology, Cardiology, Neonatal Care), and Region (North America, Europe, Asia- Pacific, RoW) – Global Forecast to 2028<\/div>\n

 Therapeutic Hypothermia Systems Market<\/a><\/strong> in terms of revenue was estimated to be worth $291 million in 2023 and is poised to reach $396 million by 2028, growing at a CAGR of 6.3% from 2023 to 2028 according to a new report by MarketsandMarkets™. The growth of this market is majorly driven by the growing number of hypothermia cases, the growing number of road accidents and sports injuries, the rise in the prevalence of traumatic brain surgery, the rise in the geriatric population, and the growing prevalence of chronic and infectious diseases.<\/p>\n

Download an Illustrative overview: https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=56601925<\/a><\/strong><\/p>\n

 <\/p>\n

The cooling devices segment is expected to account for the largest share in 2022.<\/strong><\/p>\n

The therapeutic hypothermia systems market, by product, has been segmented into cooling devices, cooling catheters, and cool caps. In 2022, the cooling devices segment dominated the products market. This segment is also estimated to grow at the highest CAGR during the forecast period. The large share is due to its increasing importance in cardiac arrest, and it is less labor-intensive and easier to use.<\/p>\n

The neurology segment held the largest market share in the therapeutic hypothermia systems market.<\/strong><\/p>\n

Based on the application, the therapeutic hypothermia systems market is segmented into Neurology, Cardiology, Neonatal care, and other applications. The neurology segment dominated the therapeutic hypothermia systems market in 2022. The large share of this segment can be primarily attributed to the growing incidence of various neurological disorders such as Traumatic brain injury, strokes, and brain and brain tumors.<\/p>\n

North America dominates the global therapeutic hypothermia systems market.<\/strong><\/p>\n

Based on the region, the therapeutic hypothermia systems market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. The North American market is driven by an increase in the incidence of cardiac arrests and neurological disorders and the availability of technologically advanced products. The Asia Pacific segment is projected to register the highest CAGR during the forecast period. Developing healthcare infrastructure, a rise in medical tourism, and government initiatives to increase the affordability of healthcare services are some of the major factors driving the growth of this regional market.<\/p>\n

Request Sample Pages: <\/strong>https:\/\/www.marketsandmarkets.com\/requestsampleNew.asp?id=56601925<\/a><\/strong><\/p>\n

Therapeutic Hypothermia Systems Market<\/strong> Dynamics:<\/strong><\/p>\n

Drivers:<\/strong><\/p>\n

 1.  Increasing number of surgical procedures<\/p>\n

Restraint:<\/strong><\/p>\n

1. Lack of awareness regarding therapeutic hypothermia systems in developing countries<\/p>\n

Opportunities:<\/strong><\/p>\n

1. Increasing growth opportunities in developing countries<\/p>\n

Challenge:<\/strong><\/p>\n

1. Lack of skilled healthcare professionals<\/p>\n

Key Market Players of <\/strong>Therapeutic Hypothermia Systems Industry<\/strong>:<\/strong><\/p>\n

Major players in the therapeutic hypothermia systems market include ZOLL Medical Corporation (Japan), Becton, Dickinson and Company (US), and Stryker Corporation (US).<\/p>\n

Breakdown of supply-side primary interviews by company type, designation, and region:<\/strong><\/p>\n